Cargando…
Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
Drug repositioning explores the reuse of non-cancer drugs to treat tumors. In this work, we evaluated the effect of the combination of chloroquine and propranolol on colorectal and triple-negative breast cancers. Using as in vitro models the colorectal cancer cell lines HCT116, HT29, and CT26, and a...
Autores principales: | Anselmino, L. E., Baglioni, M. V., Reynoso, G., Rozados, V. R., Scharovsky, O. G., Rico, M. J., Menacho-Márquez, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188563/ https://www.ncbi.nlm.nih.gov/pubmed/37193722 http://dx.doi.org/10.1038/s41598-023-34793-6 |
Ejemplares similares
-
Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
por: Anselmino, L. E., et al.
Publicado: (2021) -
Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models
por: Rico, María, et al.
Publicado: (2016) -
Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
por: Mainetti, Leandro E., et al.
Publicado: (2020) -
Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
por: Giolito, María V, et al.
Publicado: (2020) -
Metronomic chemotherapy: changing the paradigm that more is better
por: Scharovsky, O.G., et al.
Publicado: (2009)